{"nct_id":"NCT01990534","title":"A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2014-03-14","start_date_type":"ACTUAL","primary_completion_date":"2016-03-24","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-12","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["TAK"]}